163 related articles for article (PubMed ID: 32409749)
21. Novel PTCH1 and concurrent TP53 mutations in four patients with numerous non-syndromic basal cell carcinomas: The paradigm of oncogenic synergy.
Dasgeb B; Pajouhanfar S; Jazayeri A; Schoenberg E; Kumar G; Fortina P; Berger AC; Uitto J
Exp Dermatol; 2022 May; 31(5):736-742. PubMed ID: 34862824
[TBL] [Abstract][Full Text] [Related]
22. Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Stern JL; Theodorescu D; Vogelstein B; Papadopoulos N; Cech TR
Genes Dev; 2015 Nov; 29(21):2219-24. PubMed ID: 26515115
[TBL] [Abstract][Full Text] [Related]
23. Frequency of somatic mutations in
Lombardo D; Saitta C; Giosa D; Di Tocco FC; Musolino C; Caminiti G; Chines V; Franzè MS; Alibrandi A; Navarra G; Raimondo G; Pollicino T
Oncol Lett; 2020 Mar; 19(3):2368-2374. PubMed ID: 32194736
[TBL] [Abstract][Full Text] [Related]
24. Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations.
Molnár B; Galamb O; Péterfia B; Wichmann B; Csabai I; Bodor A; Kalmár A; Szigeti KA; Barták BK; Nagy ZB; Valcz G; Patai ÁV; Igaz P; Tulassay Z
BMC Cancer; 2018 Jun; 18(1):695. PubMed ID: 29945573
[TBL] [Abstract][Full Text] [Related]
25. PTCH1 gene variants rs357564, rs2236405, rs2297086 and rs41313327, mRNA and tissue expression in basal cell carcinoma patients from Western Mexico.
Zambrano-Román M; Padilla-Gutiérrez JR; Valle Y; Muñoz-Valle JF; Guevara-Gutiérrez E; Martínez-Fernández DE; Valdés-Alvarado E
J Clin Lab Anal; 2024 Feb; 38(3):e25010. PubMed ID: 38287479
[TBL] [Abstract][Full Text] [Related]
26. Basal Cell Carcinoma Gene Mutations Differ Between Asian, Hispanic, and Caucasian Patients: A Pilot Study.
Lobl M; Hass B; Clarey D; Higgins S; Sutton A; Wysong A
J Drugs Dermatol; 2021 May; 20(5):504-510. PubMed ID: 33938707
[TBL] [Abstract][Full Text] [Related]
27. TERT promoter hypermethylation is associated with poor prognosis in adrenocortical carcinoma.
Svahn F; Paulsson JO; Stenman A; Fotouhi O; Mu N; Murtha TD; Korah R; Carling T; Bäckdahl M; Wang N; Juhlin CC; Larsson C
Int J Mol Med; 2018 Sep; 42(3):1675-1683. PubMed ID: 29956721
[TBL] [Abstract][Full Text] [Related]
28. p53 mutations in basal cell carcinomas arising in routine users of sunscreens.
Rosenstein BS; Phelps RG; Weinstock MA; Bernstein JL; Gordon ML; Rudikoff D; Kantor I; Shelton R; Lebwohl MG
Photochem Photobiol; 1999 Nov; 70(5):798-806. PubMed ID: 10568172
[TBL] [Abstract][Full Text] [Related]
29. UV-radiation-specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma.
Ouhtit A; Nakazawa H; Armstrong BK; Kricker A; Tan E; Yamasaki H; English DR
J Natl Cancer Inst; 1998 Apr; 90(7):523-31. PubMed ID: 9539248
[TBL] [Abstract][Full Text] [Related]
30. Association between SNPs and Loss of Methylation Site on the CpG island of the Promoter Region of the Smoothened Gene, Potential Molecular Markers for Susceptibility to the Development of Basal Cell Carcinoma in the Brazilian Population.
Souza AM; Lopes OS; Liberato AL; Oliveira PJR; Herrero SST; Nascimento ALD; Longui CA; Carvalho Filho IR; Soares LF; Silva RBD; Burbano RR; Delatorre P; Lima EM
Asian Pac J Cancer Prev; 2020 Jan; 21(1):25-29. PubMed ID: 31983159
[TBL] [Abstract][Full Text] [Related]
31. PTCH1 gene mutations in exon 17 and loss of heterozygosity on D9S180 microsatellite in sporadic and inherited human basal cell carcinomas.
Santos DC; Zaphiropoulos PG; Neto CF; Pimentel ER; Sanches JA; Ruiz IR
Int J Dermatol; 2011 Jul; 50(7):838-43. PubMed ID: 21699520
[TBL] [Abstract][Full Text] [Related]
32. Basal Cell Carcinoma With Matrical Differentiation: Clinicopathologic, Immunohistochemical, and Molecular Biological Study of 22 Cases.
Kyrpychova L; Carr RA; Martinek P; Vanecek T; Perret R; Chottová-Dvořáková M; Zamecnik M; Hadravsky L; Michal M; Kazakov DV
Am J Surg Pathol; 2017 Jun; 41(6):738-749. PubMed ID: 28368926
[TBL] [Abstract][Full Text] [Related]
33. DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma.
Kishibuchi R; Kondo K; Soejima S; Tsuboi M; Kajiura K; Kawakami Y; Kawakita N; Sawada T; Toba H; Yoshida M; Takizawa H; Tangoku A
Int J Oncol; 2020 Jan; 56(1):315-326. PubMed ID: 31746370
[TBL] [Abstract][Full Text] [Related]
34. Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma.
Gailani MR; Leffell DJ; Ziegler A; Gross EG; Brash DE; Bale AE
J Natl Cancer Inst; 1996 Mar; 88(6):349-54. PubMed ID: 8609643
[TBL] [Abstract][Full Text] [Related]
35. Periocular Pigmented Basal Cell Carcinomas: Clinicopathologic Features and Mutational Profile.
Hassanin F; Al Hussain H; Maktabi A; Adly N; Alsuabeyl M; Abedalthagafi M; Edward DP; Strianese D
Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):475-482. PubMed ID: 35699213
[TBL] [Abstract][Full Text] [Related]
36. Clustered somatic mutations are frequent in transcription factor binding motifs within proximal promoter regions in melanoma and other cutaneous malignancies.
Colebatch AJ; Di Stefano L; Wong SQ; Hannan RD; Waring PM; Dobrovic A; McArthur GA; Papenfuss AT
Oncotarget; 2016 Oct; 7(41):66569-66585. PubMed ID: 27611953
[TBL] [Abstract][Full Text] [Related]
37. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system.
Reifenberger J; Wolter M; Weber RG; Megahed M; Ruzicka T; Lichter P; Reifenberger G
Cancer Res; 1998 May; 58(9):1798-803. PubMed ID: 9581815
[TBL] [Abstract][Full Text] [Related]
38. Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.
Palsgrove DN; Taheri D; Springer SU; Cowan M; Guner G; Mendoza Rodriguez MA; Rodriguez Pena MDC; Wang Y; Kinde I; Ricardo BFP; Cunha I; Fujita K; Ertoy D; Kinzler KW; Bivalacqua TJ; Papadopoulos N; Vogelstein B; Netto GJ
Hum Pathol; 2019 Mar; 85():1-9. PubMed ID: 30447301
[TBL] [Abstract][Full Text] [Related]
39. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
[TBL] [Abstract][Full Text] [Related]
40. Patched1 inhibits epidermal progenitor cell expansion and basal cell carcinoma formation by limiting Igfbp2 activity.
Villani RM; Adolphe C; Palmer J; Waters MJ; Wainwright BJ
Cancer Prev Res (Phila); 2010 Oct; 3(10):1222-34. PubMed ID: 20858761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
